Summary Metrics to Assess Alzheimer Disease–Related Hypometabolic Pattern with ¹⁸F-FDG PET: Head-to-Head Comparison

Abstract

The 3 tested techniques have the potential to help detect AD in research and clinical settings. Additional efforts are needed to clarify their ability to address particular scientific and clinical questions. Their incremental diagnostic value over other imaging and biologic markers makes them easier to implement by other groups for these purposes.